Abbott Says Sandoz Marketed Generic Nimbex Too Soon

Law360, New York (August 29, 2012, 2:19 PM EDT) -- An Abbott Laboratories unit sued Sandoz Inc. for $25 million in Illinois on Tuesday, claiming the rival drugmaker breached a settlement agreement reached during prior litigation by prematurely offering to sell a generic version of skeletal muscle relaxant Nimbex.

In a suit filed in Illinois federal court, AbbVie Inc. — which Abbott is scheduled to spin off as a stand-alone research-based pharmaceutical business later this year — accuses Sandoz of violating a June 2010 settlement agreement that resolved litigation over Sandoz’s bid to produce and sell...
To view the full article, register now.